Systemic Immune-Inflammation Index Predicts Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Cross-Sectional Study
Overview
Authors
Affiliations
Background And Aims: Systemic immune-inflammation index (SII) is an emerging indicator and correlated to the incidence of cardiovascular diseases. This study aimed to explore the association between SII and contrast-induced acute kidney injury (CI-AKI).
Methods: In this retrospective cross-sectional study, 4,381 subjects undergoing coronary angiography (CAG) were included. SII is defined as neutrophil count × platelet count/lymphocyte count. CI-AKI was determined by the elevation of serum creatinine (Scr). Multivariable linear and logistic regression analysis were used to determine the relationship of SII with Scr and CI-AKI, respectively. Receiver operator characteristic (ROC) analysis, structural equation model analysis, and subgroup analysis were also performed.
Results: Overall, 786 (17.9%) patients suffered CI-AKI after the intravascular contrast administration. The subjects were 67.1 ± 10.8 years wold, with a mean SII of 5.72 × 10/L. Multivariable linear regression analysis showed that SII linearly increased with the proportion of Scr elevation (β [95% confidence interval, CI] = 0.315 [0.206 to 0.424], < 0.001). Multivariable logistic regression analysis demonstrated that higher SII was associated with an increased incidence of CI-AKI ([≥12 vs. <3 × 10/L]: odds ratio, OR [95% CI] = 2.914 [2.121 to 4.003], < 0.001). Subgroup analysis showed consistent results. ROC analysis identified a good predictive value of SII on CI-AKI (area under the ROC curve [95% CI]: 0.625 [0.602 to 0.647]). The structural equation model verified a more remarkable direct effect of SII (β = 0.102, < 0.001) on CI-AKI compared to C-reactive protein (β = 0.070, < 0.001).
Conclusions: SII is an independent predictor for CI-AKI in patients undergoing CAG procedures.
Zhang L, Liu L, Yan G, Ma X, Zhu G, Dong X J Inflamm Res. 2024; 17:8727-8739.
PMID: 39553309 PMC: 11568861. DOI: 10.2147/JIR.S488900.
Li Y, Huang H, Zhou H Front Cardiovasc Med. 2024; 11:1430776.
PMID: 39512366 PMC: 11540797. DOI: 10.3389/fcvm.2024.1430776.
Wang L, Xu Y, Zhang X, Ding J, Jin J, Zong J J Inflamm Res. 2024; 17:7005-7016.
PMID: 39372595 PMC: 11456302. DOI: 10.2147/JIR.S482977.
Deng L, Chen H, Xu Q, Han K, Liu J, Chen S Rev Cardiovasc Med. 2024; 25(9):338.
PMID: 39355575 PMC: 11440391. DOI: 10.31083/j.rcm2509338.
Akkaya S, Cakmak U Medicina (Kaunas). 2024; 60(6).
PMID: 38929630 PMC: 11206129. DOI: 10.3390/medicina60061012.